1-4 of 4
Holbrook E. Kohrt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer

Jing Liu, Stephen J. Blake, Heidi Harjunpää, Kirsten A. Fairfax, Michelle C.R. Yong, Stacey Allen, Holbrook E. Kohrt, Kazuyoshi Takeda, Mark J. Smyth, Michele W.L. Teng
Journal: Cancer Research
Cancer Res (2016) 76 (18): 5288–5301.
https://doi.org/10.1158/0008-5472.CAN-16-0194
Published: 15 September 2016
View article titled, Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer
Open the PDF for Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 2323: Immune checkpoint inhibition by anti-PD-1 or CD137 co-stimulation enhances cytotoxicity towards CD30+ tumors mediated by the bispecific tetravalent CD30/CD16A TandAb AFM13

Xing Zhao, Narendiran Rajasekaran, Uwe Reusch, Jens-Peter Marschner, Martin Treder, Holbrook E. Kohrt
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2323.
https://doi.org/10.1158/1538-7445.AM2016-2323
Published: 15 July 2016
View article titled, Abstract 2323: Immune checkpoint inhibition by anti-PD-1 or CD137 co-stimulation enhances cytotoxicity towards CD30<sup>+</sup> tumors mediated by the bispecific tetravalent CD30/CD16A TandAb AFM13
Journal Articles

Abstract 2318: Discovery and validation of a novel checkpoint target preferentially expressed in the tumor microenvironment

Narendiran Rajasekaran, Amani Makkouk, Russel K. Pachynski, Aruna Azameera, Cariad Chester, Xing Zhao, Atsushi Yonezawa, Holbrook E. Kohrt
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2318.
https://doi.org/10.1158/1538-7445.AM2016-2318
Published: 15 July 2016
View article titled, Abstract 2318: Discovery and validation of a novel checkpoint target preferentially expressed in the tumor microenvironment
Journal Articles

Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells

Matthew J. Goldstein, Holbrook E. Kohrt, Roch Houot, Bindu Varghese, Jack T. Lin, Erica Swanson, Ronald Levy
Journal: Cancer Research
Cancer Res (2012) 72 (5): 1239–1247.
https://doi.org/10.1158/0008-5472.CAN-11-3375
Published: 01 March 2012
View article titled, Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
Open the PDF for Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells in another window
Includes: Supplementary data